Clinical Trial Update: Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for tirbanubulin (Klisiry) in basal cell carcinoma is reported, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Klisiry (tirbanubulin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Cell Carcinoma | Phase 2 | Status: UNKNOWN